Results 231 to 240 of about 139,564 (313)

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy

open access: bronze, 2000
Vincent Soriano   +4 more
openalex   +1 more source

Identifying key parameters for reliable assessment of entomopathogenic nematodes viability as affected by spray application stress‐related factors

open access: yesPest Management Science, EarlyView.
Commercial entomopathogenic nematodes (EPNs) were exposed to stress simulating spray application conditions, for viability assessment using different methods. Temperature impacted non‐lethal stress earlier than survival and activity, emphasizing the importance of measuring these parameters to assess pesticide application equipment (PAE) impact on EPN ...
Roberto Beltrán‐Martí   +9 more
wiley   +1 more source

Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts [PDF]

open access: bronze, 2001
Yazdan Yazdanpanah   +12 more
openalex   +1 more source

Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Intravenous natalizumab is an effective treatment for relapsing–remitting multiple sclerosis. However, the standard treatment interval of 4 weeks may be excessive for many patients. Personalized interval extension using therapeutic drug monitoring (TDM) can result in adequate drug exposure while reducing hospital visits and healthcare costs ...
Stefan P. H. van den Berg   +9 more
wiley   +1 more source

Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis

open access: yesRheumatology &Autoimmunity, EarlyView.
Recent multi‐omics studies have demonstrated that belimumab specifically targets naïve B cells and a subset of memory B cells. This observation is consistent with belimumab's established efficacy and safety profile. Abstract Belimumab is an antibody targeting the cytokine B‐cell activating factor (BAFF), which is crucial for B cell differentiation, and
Keishi Fujio   +5 more
wiley   +1 more source

Leveraging Blockchain and Smart Contracts to Combat Greenwashing in Sustainable Development

open access: yesSustainable Development, EarlyView.
ABSTRACT Blockchain technology, when combined with smart contracts, enables buyers to distinguish between greenwashed and genuinely eco‐friendly products. The presence of counterfeit items can severely impact supply chains by diminishing brand value, eroding consumer confidence, and undermining market trust.
Ragnhild Silkoset, Arne Nygaard
wiley   +1 more source

Home - About - Disclaimer - Privacy